Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tax Incentives For Biomedical Industry Are Focus Of Multiple Bills In Congress

Executive Summary

Tax incentives for the life sciences industry have a lot of allies in Congress, but any traction on reforms probably awaits broader movement on major tax or economic legislation
Advertisement

Related Content

Tax Incentives To Spur Innovation: BIO's "Big Ideas" Beyond FDA
Tax Incentives To Spur Innovation: BIO's "Big Ideas" Beyond FDA
NIH Move To Consolidate Translational Programs Is Not The Big Shakeup It's Made Out To Be, Agency Says
Tax Benefits Highlight Announced Merger Of Valeant And Biovail
Biotech Tax Credit Guidelines Clarify That All Qualifiers Will Receive An Award

Topics

Advertisement
UsernamePublicRestriction

Register

PS053498

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel